Efficacy and tolerability of paroxetine, fluvoxamine and milnacipran in depression : A result of two pooled open label randomized controlled trial

被引：0
|
作者：
Kato, M. [1 ]
Wakeno, M. [1 ]
Takekita, Y. [1 ]
Okugawa, G. [1 ]
Sakai, S. [1 ]
Kinoshita, T. [1 ]
机构：
[1] Kansai Med Univ, Moriguchi, Osaka 570, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-09-027
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial
    Keller, MB
    Ryan, ND
    Strober, M
    Klein, RG
    Kutcher, SP
    Birmaher, B
    Hagino, OR
    Koplewicz, H
    Carlson, GA
    Clarke, GN
    Emslie, GJ
    Feinberg, D
    Geller, B
    Kusumakar, V
    Papatheodorou, G
    Sack, WH
    Sweeney, M
    Wagner, DK
    Weller, EB
    Winters, NC
    Oakes, R
    McCafferty, JP
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (07): : 762 - 772
  • [2] Open trial with milnacipran to assess efficacy, tolerability and quality of life
    Zoghlami, A
    Schmid-Siegel, B
    EUROPEAN PSYCHIATRY, 2000, 15 : 447S - 447S
  • [3] A randomized open-label trial of paroxetine vs. paroxetine plus sulpiride in the treatment of major depression
    Uchida, H
    Takeuchi, H
    Nomura, K
    Suzuki, T
    Watanabe, K
    Kashima, H
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S344 - S345
  • [4] Efficacy and tolerability of rizatriptan rpd 10 mg in an open label randomized trial
    Gaul, C.
    Katsarava, Z.
    Gendolla, A.
    Diener, H. -C.
    CEPHALALGIA, 2011, 31 (01) : 50 - 50
  • [5] Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial
    Bozzatello, Paola
    Rocca, Paola
    Uscinska, Maria
    Bellino, Silvio
    CNS DRUGS, 2017, 31 (09) : 809 - 819
  • [6] Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial
    Paola Bozzatello
    Paola Rocca
    Maria Uscinska
    Silvio Bellino
    CNS Drugs, 2017, 31 : 809 - 819
  • [7] Efficacy, safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression: A randomized open label controlled trial
    Dominiak, Monika
    Antosik-Wojcinska, Anna Z.
    Goetz, Zuzanna
    Sikorska, Olga
    Stefanowski, Bogdan
    Gorostiza, Dagny
    Swiecicki, Lukasz
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 133 : 52 - 59
  • [8] Randomized, open label trial on the efficacy and tolerability of oxcarbazepine versus gabapentin in the treatment of neuropathic pain
    Jann, S.
    Sterzi, R.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 : 41 - 41
  • [9] Randomized, open label trial on the efficacy and tolerability of oxcarbazepine versus gabapentin in the treatment of neuropathic pain
    Jann, S.
    Muscia, F.
    Sterzi, R.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 (02) : 160 - 161
  • [10] Efficacy and tolerability of a "Suprabioavailable" formulation of Fenofibrate in patients with dyslipidemia: A pooled analysis of two open-label trials
    Ramjattan, BR
    Callaghan, DJG
    Theiss, U
    CLINICAL THERAPEUTICS, 2002, 24 (07) : 1105 - 1116
12345